arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Lineage Cell Therapeutics, Inc.

LCTX

$0.97 ▼ -0.06 (-5.46%) at close

18 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Lineage Cell Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $223.2M

Dividend Yield —

Revenue Growth 53.2% ↗

Op. Margin -251.6% ↘

ROIC -75.9% ↘

FCF / Share $-0.08 ↗

Trailing P/E —

Price / Book 5.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$14.56M

↑ +53.2% —

Net Income Profit after all expenses

$-63.53M

↓ -241.4% —

Operating Margin Operating profit as % of sales

-251.6%

↓ -11.3% 0th

FCF / Share Free cash flow per share

$-0.08

↑ +28.5% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	53.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+565%)	6.2% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-23%)	-39.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-590%)	238.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2884%)	137.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1622%)	-48.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-701%)	-29.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-469%)	44.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+453%)	-41.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-620%)	-15.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-298%)	34.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+327%)	18.3% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+128%)	13.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+66%)	-11.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-246%)	20.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+156%)	91.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1040%)	—	—
EPS Growth YoY (%)	-211.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	20.0% Good Good Year-over-year change in earnings per share Optimal: > 10%	42.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	N/M	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-241.4% Weak ↓ Weak Declining Year-over-year change in net income	13.4% Fair ↑ Fair Improving Year-over-year change in net income	18.2% Good ↑ Good Improving Year-over-year change in net income	38.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-108.3% Weak ↓ Weak Declining Year-over-year change in net income	-76.4% Weak ↓ Weak Declining Year-over-year change in net income	74.5% Excellent Excellent Year-over-year change in net income	-130.2% Weak Weak Year-over-year change in net income	N/M	N/M	-29.1% Weak ↑ Weak Improving Year-over-year change in net income	17.0% Good ↑ Good Improving Year-over-year change in net income	-104.8% Weak ↓ Weak Declining Year-over-year change in net income	-29.7% Weak ↑ Weak Improving Year-over-year change in net income	-47.7% Weak Weak Year-over-year change in net income	-117.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	28.5% Excellent Excellent Year-over-year change in free cash flow	30.2% Excellent Excellent Year-over-year change in free cash flow	N/M	N/M	—	—	—	—	39.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-0.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	29.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	69.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	61.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-4.5% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-19.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-16.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-10.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-13.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	10.1% Good ↓ Good Declining Compound annual revenue growth over 3 years	21.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	5.8% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	6.4% Fair Fair Compound annual revenue growth over 3 years	26.7% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	51.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	22.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	12.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	33.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-6.0% Weak ↑ Weak Improving Compound annual revenue growth over 5 years	-23.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-7.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	2.4% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	-2.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	6.0% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	13.8% Excellent Excellent Compound annual revenue growth over 5 years	22.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Operating Margin (%) (%)	-251.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1777%)	-226.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1607%)	-276.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1943%)	-153.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1121%)	—	—	—	—	—	—	—	—	—	—	-421.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2909%)	-267.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1885%)	-182.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1319%)	—
Effective Tax Rate (%) (%)	7.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	7.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	5.7% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	38.5% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.7% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-436.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3737%)	-195.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1733%)	-240.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2102%)	-178.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1589%)	—	—	-333.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2876%)	—	—	—	—	—	—	—	-372.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3204%)	-303.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2633%)	-267.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2327%)	—
FCF Margin (%) (%)	-133.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-249.0% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-326.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	4.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	-328.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-216.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-224.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.31x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.27x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.36x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-0.02x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.77x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.68x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.59x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	-1.33x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	-75.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-42.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-44.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-39.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-193.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-109.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-298.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-206.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-20.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-32.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-18.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-69.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-67.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-97.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-84.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-18.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-142.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1051%)	-23.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-258%)	-33.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-326%)	-35.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-339%)	-46.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-411%)	-21.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-10.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-169%)	-49.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-427%)	-12.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	28.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+90%)	-174.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1265%)	-99.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-766%)	-296.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2077%)	-223.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1590%)	-57.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-484%)	-29.3% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-295%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Interest Coverage (x)	-1262.72x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2386.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2473.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1732.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3785.46x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1322.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1388.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-269.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-249.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-627.31x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-102.83x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-569.46x Weak Weak Operating income divided by interest expense Optimal: > 5x	-96860.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-79.26x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.13x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-40.79M	$-45.79M	$-35.44M	$-11.36M	$-55.74M	$-32.59M	$-9.50M	$-23.59M	$-36.84M	$-22.09M	$-42.23M	$-29.49M	$-5.50M	$-4.35M	$-22.21M	$-33.32M	$-12.19M	$-12.28K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$0.06	$0.05	$0.05	$0.09	$0.03	—	—	—	$0.03	$0.06	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.28	$-0.09	$-0.12	$-0.15	$-0.26	—	—	—	$-0.17	$0.35	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.08	$-0.12	$-0.17	$0.00	$-0.15	—	—	—	$-0.28	$-0.46	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.18	$0.36	$0.36	$0.43	$0.54	$0.63	$0.75	$0.74	$1.28	$1.15	$0.30	$0.47	$0.26	$0.19	$0.58	$0.80	—	—
Tangible Book Value per Share (USD)	$0.01	$0.10	$0.04	$0.09	$0.20	$0.25	$0.36	$0.74	$1.28	$1.15	$-0.07	$-0.03	$-0.55	$-0.22	$0.20	$0.48	—	—
Basic Weighted Avg Shares (shares)	230.12M	200.19M	172.66M	169.79M	164.50M	—	—	—	114.48M	97.32M	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$47.79M	$37.02M	$20.48M	$41.02M	$64.43M	$36.23M	$51.02M	$29.55M	$35.74M	$16.80M	$34.77M	$25.34M	$992.07K	$2.79M	$21.81M	$33.09M	—	—
Total Equity (USD)	$44.55M	$78.38M	$63.42M	$73.34M	$92.22M	$96.20M	$112.96M	$93.84M	$162.64M	$117.93M	$26.89M	$36.46M	$14.80M	$9.58M	$28.65M	$38.17M	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$14.56M	$9.50M	$8.95M	$14.70M	$4.34M	$1.83M	$3.52M	$4.99M	$3.46M	$5.92M	$7.04M	$5.24M	$4.43M	$3.92M	$4.43M	$3.68M	$1.93M	—
Depreciation Expense (USD)	—	—	—	$582.00K	$663.00K	$823.00K	$1.00M	$1.08M	$947.00K	$1.18M	$1.08M	$1.05M	$656.76K	$386.46K	$373.35K	$138.66K	$34.59K	—
Net Income, GAAP (USD)	$-63.53M	$-18.61M	$-21.49M	$-26.27M	$-43.02M	$-20.65M	$-11.71M	$-45.99M	$-19.98M	$33.57M	$-46.99M	$-36.41M	$-43.88M	$-21.43M	$-16.52M	$-11.18M	$-5.14M	—
Operating Cash Flow (USD)	$-18.92M	$-23.09M	$-28.57M	$1.06M	$-23.56M	$-19.75M	$-31.95M	$-30.88M	$-30.52M	$-42.33M	—	—	—	$-19.68M	$-13.59M	$-7.73M	$-4.26M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 18 years · 68 quarters

Lineage Cell Therapeutics, Inc.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare LCTX with peers